FIELD: pharmaceutics.
SUBSTANCE: the present innovation deals with medicinal preparations designed as solution and indicated for therapeutic needs. Eye drops contain ciprofloxacin hydrochloride monohydrate being equivalent to 0.3% free foundation, a buffer system that keeps pH within 3.5-5.5 interval, as a conserving agent - benzalconium chloride and a s a stabilizer - the salt of disodium ethylenediamine tetraacetic acid, moreover, their range of osmolality values correspond to 150-450 mM/kg H2O. Eye drops should be obtained by preparing buffer system in which mannitol should be dissolved followed by the salt of disodium ethylenediamine tetraacetic acid, benzalconium chloride, ciprofloxacin hydrochloride. Then one should perform the control for the quality of obtained solution to be then filtered by applying sterilizing elements and packed. This innovation provides treatment of eyes at creating the pressure in an eye and at certain desired osmolality.
EFFECT: higher efficiency of therapy.
4 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION USED FOR TREATMENT OF PATIENTS WITH MIDDLE EAR OTITIS WITH PERFORATION AND METHOD OF COMPOSITION PREPARING | 1996 |
|
RU2165755C2 |
COMPOSITION AND METHOD FOR PREPARING CIPROFLOXACIN OPHTHALMIC OINTMENT | 2006 |
|
RU2317810C1 |
OINTMENT TYPE PANPHARMACON FOR COMPLEX TREATMENT OF ANIMAL EYE DISEASES AND METHOD OF PRODUCING THEREOF | 2017 |
|
RU2667118C1 |
OPHTHALMIC COMPOSITION, CONTAINING PHENYLEPHRINE | 2008 |
|
RU2600863C2 |
CYPROFLOXACINE SOLUTION FOR INFUSION | 2005 |
|
RU2284811C1 |
METHOD OF TREATING CATTLE THELAZIOSIS IN FIELD CONDITIONS | 2019 |
|
RU2717643C1 |
THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OTITIS MEDIA WITH PERFORATION OF THE TYMPANIC MEMBRANE | 2022 |
|
RU2782926C1 |
ALPHA-INTERFERON PREPARATION IN THE FORM OF STABLE AQUEOUS SOLUTION FOR INJECTIONS | 2004 |
|
RU2255729C1 |
CONCENTRATED PROTEIN PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2626512C2 |
ANESTHETIC COMPOSITION AND METHOD OF EYE ANESTHETIZATION | 2020 |
|
RU2812900C2 |
Authors
Dates
2005-03-20—Published
2003-06-02—Filed